Drawing for VIVAGEST

USPTO serial 79345669

VIVAGEST

Reviewed by CopyMark Law Group

Reg. 7089054Status 700Registered
Filing date
Status date
Registration date
Jun 27, 2023
Examiner
CHISOLM, KEVON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VIVAGEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kaitlyn M. Garvin

Kaitlyn M. Garvin Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Prenatal vitamins; vitamins and vitamin preparations; mixed vitamin preparations; vitamins in the form of tablets; pharmaceutical preparations for reducing the risks of complications during pregnancy; pharmaceutical preparations for reducing the risks of baby malformation; pharmaceutical preparations for improving sleep quality; pharmaceutical preparations for reducing fatigue; pharmaceutical preparations for immune regulation; pharmaceutical preparations for immune system regulation; pharmaceutical preparations for prevention of immune system diseases and disorders; pharmaceutical preparations for strengthening the immune system; pharmaceutical preparations for enhancing breast milk production and enrichment; pharmaceutical preparations for improving fertility; pharmaceutical preparations for delaying the aging of the ovaries; hormones for medical use; hormone preparations for pharmaceutical use; pharmaceutical preparations for hormonal disorder treatment; mixed-hormone pharmaceutical preparations; pharmaceutical preparations for the treatment of dry skin caused by pregnancy; pharmaceutical preparations for the treatment of vaginal dryness; pharmaceutical preparations for regulation of cervical mucus abnormalities; medicines for regulating the menstrual cycle; medicines for fighting ovarian dystrophy; pharmaceutical preparations for fighting ovulation disorders; pharmaceutical preparations for fighting micro-nutritional deficiency; pharmaceutical preparations for oocyte stimulation; pharmaceutical preparations for facilitating embryo implantationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 24, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 29, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 29, 2023FIMPFINAL DISPOSITION PROCESSED—
Sep 27, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 27, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 27, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 22, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance